-
BARDA to give Moderna up to $483 million for COVID-19 vaccine development
europeanpharmaceuticalreview
April 22, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) will fund Moderna’s COVID-19 vaccine candidate mRNA-1273 through Phase II and III clinical trials to FDA licensure.
-
University of Georgia’s Covid-19 vaccine shows promise in test models
pharmaceutical-technology
April 22, 2020
A Covid-19 vaccine candidate developed by a research team at the University of Georgia (UGA) College of Veterinary Medicine has shown promise in test models.
-
US NIH to launch international alliance for Covid-19 drugs and vaccine
pharmaceutical-technology
April 21, 2020
The US National Institutes of Health (NIH) is set to launch a public-private partnership, which will bring together health agencies and pharmaceutical companies to accelerate Covid-19 drugs and vaccines.
-
ABL Supports Fill/Finish of COVID-19 Vaccine Candidate
contractpharma
April 20, 2020
Utilizes its aseptic fill/finish facility to support confidential clients' COVID-19 vaccine development.
-
Open letter calls for UK government to stop pharma profiting from COVID-19
europeanpharmaceuticalreview
April 20, 2020
An open letter from aid organisations and academics has called on the UK government to stipulate conditions for pharmaceutical companies using public funding for COVID-19 vaccines.
-
University of Waterloo to develop nasal vaccine for Covid-19
pharmaceutical-technology
April 20, 2020
University of Waterloo researchers in Canada are developing a DNA-based vaccine candidate that can be given via nasal route to protect from Covid-19 infection.
-
US BARDA commits up to $483m for Moderna Covid-19 vaccine
pharmaceutical-technology
April 20, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) has committed up to $483m to support the development of the Moderna mRNA vaccine candidate, mRNA-1273, against Covid-19.
-
Sir Andrew Witty to co-lead WHO COVID-19 vaccine effort
pharmatimes
April 17, 2020
Ex-GSK chief Sir Andrew Witty is to lead co-lead the World Health Organisation effort to speed up development of a COVID-19 vaccine.
-
Sinovac Biotech to move ahead with COVID-19 vaccine trial in China
pharmaceutical-business-review
April 17, 2020
Sinovac Biotech has secured approval in China to move ahead with a human clinical trial on an inactivated vaccine candidate against the SARS-CoV-2 virus (novel coronavirus or COVID-19).
-
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
americanpharmaceuticalreview
April 17, 2020
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.